Skip to content
Press Releases
Filter Releases
 
Press Releases
Nov 28, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced that data confirming the analytical validity of the company's Envisia™ Genomic Classifier have been published online in the journal BMC Pulmonary Medicine. The findings add to the growing body of evidenc...
PDF
Nov 15, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Piper Jaffray 29th Annual Healthcare Conference on Tuesday, November 28, 2017 at 9:30 a.m. Eastern Time in New York, NY. ...
PDF
Nov 9, 2017
- Interim CATALYST Study Findings Presented at PFF Summit - SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced that new data for the Envisia™ Genomic Classifier were presented today and demonstrate that the test - in real-world clinical scen...
PDF
Nov 6, 2017
Reports Revenue of $17.5 Million for the Third Quarter 2017Highlights Business ProgressConference Call and Webcast Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the third quart...
PDF
Nov 3, 2017
Greater than 50 Percent Reduction in Patients Classified as Low Risk for Lung Cancer SAN FRANCISCO--(BUSINESS WIRE)-- Correcting quote attribution in the third paragraph of release issued Nov. 1, 2017. The corrected release reads: VERACYTE AN...
PDF
Nov 2, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 9, 2017 at 3:00 p.m. Eastern Time in New York, N...
PDF
Oct 26, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced today that it will report its third quarter 2017 financial results after the close of market on Monday, November 6, 2017. Following the announcement, Veracyte will host a conference call and webcast at 4:30 p.m. Easter...
PDF
Oct 21, 2017
Next-Generation Test is First to Distinguish Benign from Cancerous Hürthle Cells; New Algorithms Identified MTC with 100 Percent Sensitivity and Specificity SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced that data...
PDF
Oct 20, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ: VCYT) announced that data presented at the 87th Annual Meeting of the American Thyroid Association (ATA) being held October 18-22 in Victoria, BC, Canada demonstrate the accuracy of identification of BRAF V600E and parathyroid tissue ...
PDF
Oct 19, 2017
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (NASDAQ:VCYT) today announced that data from a prospective clinical utility study demonstrating the ability of the Percepta® Bronchial Genomic Classifier to safely reduce unnecessary invasive procedures in lung cancer screening and diagno...
PDF
Page:
...
Next Last